Leggett & Platt Reports Weak Q1 Results, Withdraws 2026 Guidance Amidst Pending Acquisition
LEG sits 40% above its 52-week low of $7.86.
Summary
Leggett & Platt reported a 10% decline in Q1 sales and a significant drop in adjusted EPS, alongside negative operating cash flow, and formally withdrew its 2026 financial guidance due to the pending Somnigroup acquisition.
Key Events · Earnings and Guidance · LEG
-
Weak First Quarter Financials
First quarter sales decreased 10% to $918 million compared to the prior year, with organic sales down 5% and volume down 9%. Adjusted EPS fell to $0.15, a $0.09 decrease from adjusted 1Q25 EPS.
-
Negative Operating Cash Flow
Operating cash flow was negative $56 million in the first quarter, a $63 million decrease versus the first quarter of 2025, reflecting a larger use of working capital and lower earnings.
-
2026 Guidance Withdrawn
The company formally withdrew its previously issued 2026 financial guidance, citing the pending acquisition by Somnigroup International Inc. as the reason.
-
Increased Debt Leverage
Net Debt to trailing 12-month adjusted EBITDA increased to 2.75x from 2.36x at the end of 2025.
Analysis · LEG · Manufacturing
Leggett & Platt's first-quarter results show significant operational challenges, with sales and adjusted EPS declining substantially. The negative operating cash flow is a notable concern, indicating a drain on liquidity. The withdrawal of 2026 guidance, while attributed to the pending Somnigroup acquisition, removes future visibility and suggests a difficult operating environment. Investors should monitor the progress of the acquisition and the company's ability to manage ongoing demand weakness and cost pressures.
At the time of this filing, LEG was trading at $11.00 on NYSE in the Manufacturing sector, with a market capitalization of approximately $1.6B. The 52-week trading range was $7.86 to $13.00. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.